Contact:  

Darcie Peck
Investor Relations
(203) 845-5237
dpeck@imshealth.com
 

NORWALK, CT, July 14, 2008 -- The Board of Directors of IMS Health (NYSE: RX) today declared a regular third-quarter 2008 dividend of $0.03 per share, payable on September 5, 2008 to shareholders of record at the close of business on August 1, 2008.

About IMS
Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.2 billion in 2007 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.